R Squared’s Tenaya Therapeutics TNYA Stock Holding History

R Squared’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.3K	Buy	31,503 +20,295	+181%	+$15.4K	0.01%	485
2026 Q1	$7.76K	Buy	+11,208	New	+$8.27K	﹤0.01%	475

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

R Squared's TNYA Position: Q2 2026 in Review

R Squared increased its Tenaya Therapeutics (TNYA) stake by 181% in Q2 2026, buying an estimated $15.4K and bringing the position to 31,503 shares worth $23.3K. The position accounts for 0.01% of the portfolio, ranked #485.

R Squared first reported a position in TNYA in Q1 2026 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

R Squared held 31,503 shares of Tenaya Therapeutics worth $23.3K as of Q2 2026.
R Squared bought 20,295 Tenaya Therapeutics shares in Q2 2026, an estimated $15.4K.
Tenaya Therapeutics made up 0.01% of R Squared's portfolio in Q2 2026, its #485 holding.
R Squared first reported a position in Tenaya Therapeutics in Q1 2026 and has held it in 2 quarters since.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.